ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo

Molecular and Cellular Biology

Volumn 29, Issue 18, 2009, Pages 4935-4948

  Muraoka Cook, Rebecca S ^a   Sandahl, Melissa A ^a   Strunk, Karen E ^a   Miraglia, Leah C ^a   Husted, Carty ^a   Hunter, Debra M ^a   Elenius, Klaus ^b   Chodosh, Lewis A ^c   Earp III, H Shelton ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA CATENIN; CYCLIN D1; CYTOKERATIN; CYTOPLASM PROTEIN; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 4; PROTEIN CTY2; PROTEIN CYT1; STAT5A PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPROTEIN; MILK PROTEIN; STAT5 PROTEIN; STAT5A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; GROWTH INHIBITION; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE C MYC; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; ALTERNATIVE RNA SPLICING; ANIMAL; CELL LINE; CELL NUCLEUS; CHEMISTRY; CYTOLOGY; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; PUBERTY; SIGNAL TRANSDUCTION; UDDER;

ALTERNATIVE SPLICING; AMINO ACID MOTIFS; AMINO ACIDS; ANIMALS; BETA CATENIN; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MILK PROTEINS; PHOSPHORYLATION; PREGNANCY; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PUBERTY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 70249096642     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01705-08     Document Type: Article

References (55)

1. Aqeilan, R. I., V. Donati, E. Gaudio, M. S. Nicoloso, M. Sundvall, A. Korhonen, J. Lundin, J. Isola, M. Sudol, H. Joensuu, C. M. Croce, and K. Elenius. 2007. Association of Wwox with ErbB4 in breast cancer. Cancer Res. 67:9330-9336. (Pubitemid 47535922)
2. Aqeilan, R. I., V. Donati, A. Palamarchuk, F. Trapasso, M. Kaou, Y. Pekarsky, M. Sudol, and C. M. Croce. 2005. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res. 65:6764-6772.
3. Barnes, N. L., S. Khavari, G. P. Boland, A. Cramer, W. F. Knox, and N. J. Bundred. 2005. Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin. Cancer Res. 11:2163-2168.
4. Chen, Q. Q., X. Y. Chen, Y. Y. Jiang, and J. Liu. 2005. Identification of novel nuclear localization signal within the ErbB-2 protein. Cell Res. 15:504-510. (Pubitemid 41653921)
5. Elenius, K., C. J. Choi, S. Paul, E. Santiestevan, E. Nishi, and M. Klagsbrun. 1999. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase. Oncogene 18:2607-2615. (Pubitemid 29216683)
6. Elenius, K., G. Corfas, S. Paul, C. J. Choi, C. Rio, G. D. Plowman, and M. Klagsbrun. 1997. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J. Biol. Chem. 272:26761-26768.
7. Feng, S. M., R. S. Muraoka-Cook, D. Hunter, M. A. Sandahl, L. S. Caskey, K. Miyazawa, A. Atfi, and H. S. Earp III. 2009. The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation. Mol. Cell. Biol. 29:892-906.
8. Feng, S. M., C. I. Sartor, D. Hunter, H. Zhou, X. Yang, L. S. Caskey, R. Dy, R. S. Muraoka-Cook, and H. S. Earp III. 2007. The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation. Mol. Endocrinol. 21:1861-1876.
9. Gullick, W. J. 2003. c-erbB-4/HER 4, friend or foe? J. Pathol. 200:279-281.
10. Gunther, E. J., G. K. Belka, G. B. Wertheim, J. Wang, J. L. Hartman, R. B. Boxer, and L. A. Chodosh. 2002. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 16:283-292.
11. Hazan, R. B., and L. Norton. 1998. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J. Biol. Chem. 273:9078-9084.
12. Holbro, T., and N. E. Hynes. 2004. ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol. 44:195-217.
13. Jones, F. E., J. P. Golding, and M. Gassmann. 2003. ErbB4 signaling during breast and neural development: novel genetic models reveal unique ErbB4 activities. Cell Cycle 2:555-559.
14. Jones, F. E., T. Welte, X. Y. Fu, and D. F. Stern. 1999. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J. Cell Biol. 147:77-88.
15. Junttila, T. T., M. Sundvall, M. Lundin, J. Lundin, M. Tanner, P. Harkonen, H. Joensuu, J. Isola, and K. Elenius. 2005. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res. 65: 1384-1393. (Pubitemid 40270166)
16. Kainulainen, V., M. Sundvall, J. A. Määttä, E. Santiestevan, M. Klagsbrun, and K. Elenius. 2000. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis. J. Biol. Chem. 275:8641-8649.
17. Kim, J., W. J. Jahng, D. Di Vizio, J. S. Lee, R. Jhaveri, M. A. Rubin, A. Shisheva, and M. R. Freeman. 2007. The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res. 67:9229-9237. (Pubitemid 47535910)
18. Lee, H. J., K. M. Jung, Y. Z. Huang, L. B. Bennett, J. S. Lee, L. Mei, and T. W. Kim. 2002. Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. J. Biol. Chem. 277:6318-6323.
19. Lin, S. Y., K. Makino, W. Xia, A. Matin, Y. Wen, K. Y. Kwong, L. Bourguignon, and M. C. Hung. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3:802-808.
20. Linggi, B., Q. C. Cheng, A. R. Rao, and G. Carpenter. 2006. The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase. Oncogene 25:160-163. (Pubitemid 43050015)
21. Long, W., K. U. Wagner, K. C. Lloyd, N. Binart, J. M. Shillingford, L. Hennighausen, and F. E. Jones. 2003. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130:5257-5268. (Pubitemid 37369683)
22. Määttä, J. A., M. Sundvall, T. T. Junttila, L. Peri, V. J. Laine, J. Isola, M. Egeblad, and K. Elenius. 2006. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol. Biol. Cell 17:67-79.
23. Muraoka, R. S., A. E. Lenferink, J. Simpson, D. M. Brantley, L. R. Roebuck, F. M. Yakes, and C. L. Arteaga. 2001. Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function. J. Cell Biol. 153:917-932.
24. Muraoka-Cook, R. S., L. S. Caskey, M. A. Sandahl, D. M. Hunter, C. Husted, K. E. Strunk, C. I. Sartor, W. A. Rearick, Jr., W. McCall, M. K. Sgagias, K. H. Cowan, and H. S. Earp III. 2006. Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. Mol. Cell. Biol. 26:6412-6424.
25. Muraoka-Cook, R. S., M. A. Sandahl, C. Husted, D. M. Hunter, L. C. Miraglia, S.-M. Feng, K. Elenius, and H. S. Earp III. 2006. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol. Biol. Cell 17:4118-4129.
26. Naresh, A., W. Long, G. A. Vidal, W. C. Wimley, L. Marrero, C. I. Sartor, S. Tovey, T. G. Cooke, J. M. Bartlett, and F. E. Jones. 2006. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res. 66:6412-6420.
27. Ni, C. Y., M. P. Murphy, T. E. Golde, and G. Carpenter. 2001. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294:2179-2181. (Pubitemid 33150677)
28. Offterdinger, M., C. Schofer, K. Weipoltshammer, and T. W. Grunt. 2002. c-erbB-3: a nuclear protein in mammary epithelial cells. J. Cell Biol. 157: 929-939. (Pubitemid 34839768)
29. Omerovic, J., L. Santangelo, E. M. Puggioni, J. Marrocco, C. Dall'Armi, C. Palumbo, F. Belleudi, L. Di Marcotullio, L. Frati, M. R. Torrisi, G. Cesareni, A. Gulino, and M. Alimandi. 2007. The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation. FASEB J. 21:2849-2862. (Pubitemid 47372752)
30. Piedra, J., D. Martinez, J. Castano, S. Miravet, M. Dunach, and A. G. de Herreros. 2001. Regulation of β-catenin structure and activity by tyrosine phosphorylation. J. Biol. Chem. 276:20436-20443.
31. Polakis, P. 2000. Wnt signaling and cancer. Genes Dev. 14:1837-1851.
32. Rio, C., J. D. Buxbaum, J. J. Peschon, and G. Corfas. 2000. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 275:10379-10387.
33. Sartor, C. I., H. Zhou, E. Kozlowska, K. Guttridge, E. Kawata, L. Caskey, J. Harrelson, N. Hynes, S. Ethier, B. Calvo, and H. S. Earp III. 2001. HER4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol. Cell. Biol. 21:4265-4275.
34. Schroeder, J. A., M. C. Adriance, E. J. McConnell, M. C. Thompson, B. Pockaj, and S. J. Gendler. 2002. ErbB-β-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. J. Biol. Chem. 277:22692-22698.
35. Schroeder, J. A., and D. C. Lee. 1998. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 9:451-464.
36. Shibata, T., A. Ochiai, Y. Kanai, S. Akimoto, M. Gotoh, N. Yasui, R. Machinami, and S. Hirohashi. 1996. Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells. Oncogene 13:883-889. (Pubitemid 26329074)
37. Srinivasan, R., C. E. Gillett, D. M. Barnes, and W. J. Gullick. 2000. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. Cancer Res. 60:1483-1487. (Pubitemid 30183410)
38. Stern, D. F. 2003. ErbBs in mammary development. Exp. Cell Res. 284: 89-98.
39. HER4. Cancer Res. 67:6582-6590.
40. Sultan, A. S., J. Xie, M. J. LeBaron, E. L. Ealley, M. T. Nevalainen, and H. Rui. 2005. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24:746-760.
41. Sundvall, M., A. Korhonen, I. Paatero, E. Gaudio, G. Melino, C. M. Croce, R. I. Aqeilan, and K. Elenius. 2008. Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms. Proc. Natl. Acad. Sci. USA 105:4162-4167.
42. Sundvall, M., L. Peri, J. A. Määttä, D. Tvorogov, I. Paatero, M. Savisalo, O. Silvennoinen, Y. Yarden, and K. Elenius. 2007. Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains. Oncogene 26:6905-6914. (Pubitemid 47609080)
43. Suo, Z., B. Risberg, M. G. Kalsson, et al. 2002. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. J. Pathol. 196:17-25.
44. Tidcombe, H., A. Jackson-Fisher, K. Mathers, D. F. Stern, M. Gassmann, and J. P. Golding. 2003. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc. Natl. Acad. Sci. USA 100:8281-8286.
45. Tovey, S. M., C. J. Witton, J. M. Bartlett, P. D. Stanton, J. R. Reeves, and T. G. Cooke. 2004. Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling. Breast Cancer Res. 6:R246-R251.
46. Vidal, G. A., A. Narres, L. Marrero, and F. E. Jones. 2005. Presenilindependent gamma-secretase processing regulates multiple ERBB4/HER4 activities. J. Biol. Chem. 280:19777-19783.
47. Wang, S. C., H. C. Lien, W. Xia, I. F. Chen, H. W. Lo, Z. Wang, M. Ali-Seyed, D. F. Lee, G. Bartholomeusz, F. Ou-Yang, D. K. Giri, and M. C. Hung. 2004. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6:251-261.
48. Williams, C. C., J. G. Allison, G. A. Vidal, M. E. Burow, B. S. Beckman, L. Marrero, and F. E. Jones. 2004. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167:469-478.
49. Wiseman, S. M., N. Makretsov, T. O. Nielsen, B. Gilks, E. Yorida, M. Cheang, D. Turbin, K. Gelmon, and D. G. Huntsman. 2005. Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival. Cancer 103:1770-1777.
50. Witton, C. J., J. R. Reeves, J. J. Going, T. G. Cooke, and J. M. Bartlett. 2003. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. J. Pathol. 200:290-297. (Pubitemid 36827302)
51. Wong, G. T., B. J. Gavin, and A. P. McMahon. 1994. Differential transformation of mammary epithelial cells by Wnt genes. Mol. Cell. Biol. 14:6278-6286.
52. Xie, J., M. J. LeBaron, M. T. Nevalainen, and H. Rui. 2002. Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. J. Biol. Chem. 277:14020-14030.
53. Yu, W. H., J. F. Woessner, Jr., J. D. McNeish, and I. Stamenkovic. 2002. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16:307-323.
54. Zeng, F., M. Z. Zhang, A. B. Singh, R. Zent, and R. C. Harris. 2007. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis. Mol. Biol. Cell 18:4446-4456.
55. Zhu, Y., L. L. Sullivan, S. S. Nair, C. C. Williams, A. K. Pandey, L. Marrero, R. K. Vadlamudi, and F. E. Jones. 2006. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res. 66:7991-7998. (Pubitemid 44299163)